ASO Visual Abstract: Does Additional Margin Excision During Pegulicianine Fluorescence-Guided Surgery (pFGS) Affect Patient Breast Satisfaction?
The authors are currently receiving research funding from Lumicell to collect follow-up and recurrence data for trial patients
Authors
- Nina Tamirisa (ORCID: https://orcid.org/0000-0002-0451-0759)
- E. Shelley Hwang (ORCID: https://orcid.org/0000-0002-8571-1148)
- Kelly K. Hunt (ORCID: https://orcid.org/0000-0001-9156-8723)
- Logan R. Holt (ORCID: https://orcid.org/0009-0006-7537-7533)
- Barbara Lynn Smith (ORCID: https://orcid.org/0000-0003-4281-665X)
- Kate Porta Smith (ORCID: https://orcid.org/0000-0002-1685-2051)
- Peter William Blumencranz
- David John Carr (ORCID: https://orcid.org/0000-0002-5421-5395)
- Irene Wapnir (ORCID: https://orcid.org/0000-0003-2062-2854)
- Kyle J. Anderman
- Jorge M. Ferrer
- Abigail E. Daly
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Novant Health (US)
- Lumicell (United States) (US)
- BayCare Health System (US)
- Stanford Medicine (US)
- Duke University Health System (US)
- Mass General Brigham (US)
- Stanford University (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2026-10-16
- DOI
- https://doi.org/10.1245/s10434-026-20588-2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- AstraZeneca
- University of Texas MD Anderson Cancer Center
- Daiichi Sankyo Europe